The US Drug Enforcement Administration (DEA) further extended flexibilities that allow providers to prescribe controlled substances via telemedicine without first performing an in-person visit. The ...
The US Drug Enforcement Administration (DEA) further extended flexibilities that allow providers to prescribe controlled substances via telemedicine without first performing an in-person visit. The ...
In an April 2 letter, a group of over 200 stakeholders urged the Drug Enforcement Administration (DEA) to release a revised proposed rule that would “permit and regulate the prescribing of controlled ...
With the DEA’s final rule, EMS organizations’ legal responsibilities under PPAEMA have now been fully spelled out and ...
Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare ...
The U.S. Drug Enforcement Agency and Health and Human Services announced the Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications, meant to ...
The U.S. Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) have issued a Fourth Temporary Extension of the COVID-19 Telemedicine Flexibilities for the ...
The Drug Enforcement Agency's (DEA) Office of Diversion Control regulates the purchase, storage and use of controlled substances under Title 21 Code of Federal Regulations Part 1300. The Office of ...
The ability to import and export controlled substances, ranging from Schedule I to Schedule V, allows Vici Health Sciences to facilitate the global movement of investigational drugs and materials for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results